Carbon vs. Metal marker for breast cancer lymph node marking after chemo
Part of Cancer, Skin clinical trials.
This trial compares two methods to mark lymph nodes in the armpit after chemotherapy for breast cancer. It tests whether a carbon-based marker works as well as a metallic marker to help surgeons find and remove the right lymph nodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman 18 years or older.
- You have been diagnosed with breast cancer that has spread to lymph nodes (stage T1-3N1M0).
- You are healthy enough for daily activities (ECOG 0-1).
- You are scheduled to receive chemotherapy or other therapy before surgery.
- You agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a more targeted surgery to remove cancer-involved lymph nodes in the armpit after you finish chemotherapy before surgery. It may help doctors better remove affected nodes while avoiding unnecessary tissue removal.
This study uses a tiny magnetic marker (called Magseed) placed in a breast cancer–affected underarm lymph node, then tracks whether surgeons can find and remove the correct nodes after chemotherapy. It may help reduce the chance of missing cancer in the underarm while aiming for more accurate surgery.
This trial tests a new method using magnetic markers (Magtrace and Magseed) to find lymph nodes before chemotherapy. It may help doctors better target the lymph nodes that need to be removed during breast cancer surgery.
This trial tests a new method to find and remove lymph nodes in the armpit after chemotherapy shrinks breast cancer. It uses a safe blue dye to help surgeons identify which nodes to remove, potentially reducing complications while ensuring thorough treatment.
This trial compares two ways to treat the underarm lymph nodes in people whose sentinel lymph node still shows limited cancer after chemotherapy and hormone treatment. It may help find which approach controls cancer better with fewer side effects.
This trial compares a new imaging method (LuminoMark) to the usual approach for finding and removing cancer in the lymph nodes under the arm during surgery. It may help doctors more precisely target and remove the affected nodes, which could improve treatment and reduce side effects.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.